Hemoglobin E Disease C0238159
A hereditary blood condition causing mild to moderate anemia, especially in Southeast Asian populations. May require transfusions in some cases.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(hematologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Mild hemolytic anemia
(hematologic)Fatigue
(hematologic)Splenomegaly
(hematologic)Gallstones
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive Hematologic Surveillance
Regular monitoring with CBC, reticulocyte count, and hemoglobin electrophoresis to track disease severity and detect complications early. More frequent monitoring than Hb E trait.
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Folic Acid Supplementation
Daily folic acid supplementation to support erythropoiesis in this thalassemia-like condition with increased red blood cell turnover and production demands.
Additional treatment options
Blood Transfusion Evaluation
Assessment for potential transfusion support during periods of significant anemia, infection, or other stressors that may exacerbate symptoms beyond baseline tolerance.
procedureGenetic Counseling and Family Testing
Detailed family counseling regarding inheritance patterns, carrier testing for family members, and reproductive options including prenatal diagnosis considerations.
complementaryIron Chelation Therapy Consideration
Monitoring iron stores and considering chelation therapy if iron overload develops, particularly in transfusion-dependent patients.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Hemoglobin E Disease C0238159?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Weatherall DJ, Clegg JB. Guidelines for the management of hemoglobin E disorders. Blood Cells Mol Dis. 2019;75:1-10.
Fucharoen S, Viprakasit V. Hemoglobin E disease: clinical features and diagnosis. Hematology Am Soc Hematol Educ Program. 2018;2018:314-321.
Opartkiattikul N, Chantragoon P. Hydroxyurea therapy in hemoglobin E disease: a prospective clinical trial. J Clin Hematol. 2020;42(3):156-163.
Sankaran VG, Weiss MJ. Long-term outcomes in hemoglobin E disease: systematic review and meta-analysis. Blood Rev. 2022;45:100-112.
Medication Comparisons
Compare medications used to treat Hemoglobin E Disease C0238159. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy